Changcheng Luo
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
A Single-Cell Multiomics Pipeline Maps YBX1 as a Functional Biomarker for Immune Evasion and Therapeutic Resistance in Prostate Adenocarcinoma.
Journal: Human mutation
Published: March 16, 2026
Hydrostatic pressure regulates glutamine metabolism to promote bladder fibroblast activation via the Piezo1/YAP1/GLS1 axis.
Journal: Journal of translational medicine
Published: September 01, 2025
Targeting ROCK1/YAP1 Axis Ameliorates Inflammation-Induced Prostatic Hyperplasia via Stabilising SIRT1-Dependent Mitochondrial Dynamics.
Journal: Cell proliferation
Published: March 22, 2025
1470 nm diode laser enucleation versus bipolar transurethral resection of the prostate for the surgical management of benign prostatic hyperplasia: a randomized comparison.
Journal: Lasers in medical science
Published: February 14, 2025
The Expression and Function of Piezo Channels in Bladder.
Journal: Bladder (San Francisco, Calif.)
Published: July 19, 2023
YAP1 Recognizes Inflammatory and Mechanical Cues to Exacerbate Benign Prostatic Hyperplasia via Promoting Cell Survival and Fibrosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 26, 2023
High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression.
Journal: Scientific reports
Published: June 10, 2023
saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation.
Journal: Biochemical and biophysical research communications
Published: November 28, 2022
Cryptotanshinone modulates proliferation, apoptosis, and fibrosis through inhibiting AR and EGFR/STAT3 axis to ameliorate benign prostatic hyperplasia progression.
Journal: European journal of pharmacology
Published: June 20, 2022
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis.
Journal: Journal of immunology research
Published: November 29, 2021
Tissue Kallikrein Protects Rat Prostate against the Inflammatory Damage in a Chronic Autoimmune Prostatitis Model via Restoring Endothelial Function in a Bradykinin Receptor B2-Dependent Way.
Journal: Oxidative medicine and cellular longevity
Published: October 17, 2021
Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates.
Journal: Oxidative medicine and cellular longevity
Published: September 16, 2020
Last Updated: 09/26/2026